Loading video...

Video Failed to Load

Go Home

Patients and scientists have been completely disconnected from one another. DeSci aims to bridge this gap. Paul Kohlhaas bio/acc sharing insights on a new approach to drug development

BioProtocol's profile picture

Bio Protocol

116,142 subscribers

11,746 views • 1 year ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

"The pharmaceutical drug development model today still operates like software in the 90s." - Paul Kohlhaas bio/acc
1:17

"The pharmaceutical drug development model today still operates like software in the 90s." - Paul Kohlhaas bio/acc

Bio Protocol

10,061 views • 1 year ago

How do we 1000x DeSci in 2025? Starting in Q1, the BIO Launchpad is evolving into an autonomous, community-owned protocol that makes BioDAO creation open, accessible and fun. $BIO holders curate and get whitelisted in new BioDAOs. Paul Kohlhaas bio/acc joined BlockBeats｜We're hiring! to preview the mechanics.
3:50

How do we 1000x DeSci in 2025? Starting in Q1, the BIO Launchpad is evolving into an autonomous, community-owned protocol that makes BioDAO creation open, accessible and fun. $BIO holders curate and get whitelisted in new BioDAOs. Paul Kohlhaas bio/acc joined BlockBeats｜We're hiring! to preview the mechanics.

Bio Protocol

76,314 views • 1 year ago

CZ CZ 🔶 BNB said : “ #AI and #DeSci are the next main themes of Crypto.” Renee 佳瑞Renée (💜,💛) shared me this video to cheer me up😂😂 Guys, cheer up 😂😂 Paul Kohlhaas bio/acc Patrick Joyce #BNB #SOL #DeSciCult
0:23

CZ CZ 🔶 BNB said : “ #AI and #DeSci are the next main themes of Crypto.” Renee 佳瑞Renée (💜,💛) shared me this video to cheer me up😂😂 Guys, cheer up 😂😂 Paul Kohlhaas bio/acc Patrick Joyce #BNB #SOL #DeSciCult

Dr.UZ

29,117 views • 1 year ago

How does DeSci bring science to consumers faster? At DeSci Abu Dhabi, Paul Kohlhaas bio/acc announced that Bio is building a ’Shopify’ for science-backed health products. DeSci’s edge: > Community-driven feedback & development bring science to market faster > Token incentives scale organic demand > BioAgents drive personalization & consumer discovery Initial featured products will include DermaDAO skin care, HairDAO 💈 hair-loss treatments, Cerebrum DAO 🧠 brain health supplement & more. More soon! Watch the full DeSci Abu Dhabi livestream below ↓
1:44

How does DeSci bring science to consumers faster? At DeSci Abu Dhabi, Paul Kohlhaas bio/acc announced that Bio is building a ’Shopify’ for science-backed health products. DeSci’s edge: > Community-driven feedback & development bring science to market faster > Token incentives scale organic demand > BioAgents drive personalization & consumer discovery Initial featured products will include DermaDAO skin care, HairDAO 💈 hair-loss treatments, Cerebrum DAO 🧠 brain health supplement & more. More soon! Watch the full DeSci Abu Dhabi livestream below ↓

Bio Protocol

11,314 views • 6 months ago

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇
23:18

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇

DeSci News

34,166 views • 5 months ago

9/ @bioprotocol | $BIO BIO accelerates biotech through a decentralized curation and liquidity protocol, empowering patients, scientists, and biotech professionals. Sector: DeSci ➢ Price: $0.25 ➢ Market Cap: $400M
0:36

9/ @bioprotocol | $BIO BIO accelerates biotech through a decentralized curation and liquidity protocol, empowering patients, scientists, and biotech professionals. Sector: DeSci ➢ Price: $0.25 ➢ Market Cap: $400M

Rekt Fencer

10,437 views • 1 year ago

Let’s work on firing your hands with a gap-to-gap approach! #baseball #training #michigan #development
1:15

Let’s work on firing your hands with a gap-to-gap approach! #baseball #training #michigan #development

Tracy Smith

24,497 views • 6 months ago

Our new recommendations published today in The Lancet Oncology spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ #OncTwitter
0:35

Our new recommendations published today in The Lancet Oncology spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ #OncTwitter

ASCO

48,233 views • 2 years ago

Yesterday, Paul Kohlhaas bio/acc important insights about Aubrai in a tweet; later in the evening, he presented the same information live at Bio Protocol TV’s Silicon Valley studios. Aubrey de Grey Bio Protocol Has anyone among you ever dreamed of achieving something they were told was impossible?
1:11

Yesterday, Paul Kohlhaas bio/acc important insights about Aubrai in a tweet; later in the evening, he presented the same information live at Bio Protocol TV’s Silicon Valley studios. Aubrey de Grey Bio Protocol Has anyone among you ever dreamed of achieving something they were told was impossible?

0xdenver

11,834 views • 10 months ago

IMPORTANT MESSAGE FROM DR AMBRISH MITHAL I have learnt from friends and patients that an advertisement for a drug Diofin for "curing" diabetes is being widely circulated, supposedly endorsed by me. The claim is accompanied with detailed descriptions about my research saying that I discovered and developed this drug. I wish to say that this is completely false. I do not know of this drug and I have not been involved in its development. I have never even heard of this drug prior to this episode. The post also refers to minute details of my life, education and qualifications to seem authentic. All these personal details are also false. I would like to reiterate that this advertisement is a complete fabrication. Please do not get misled. Meanwhile appropriate steps have been initiated to address this false advertising.
1:11

IMPORTANT MESSAGE FROM DR AMBRISH MITHAL I have learnt from friends and patients that an advertisement for a drug Diofin for "curing" diabetes is being widely circulated, supposedly endorsed by me. The claim is accompanied with detailed descriptions about my research saying that I discovered and developed this drug. I wish to say that this is completely false. I do not know of this drug and I have not been involved in its development. I have never even heard of this drug prior to this episode. The post also refers to minute details of my life, education and qualifications to seem authentic. All these personal details are also false. I would like to reiterate that this advertisement is a complete fabrication. Please do not get misled. Meanwhile appropriate steps have been initiated to address this false advertising.

Dr Ambrish Mithal

17,214 views • 21 days ago

🚨NEW EPISODE🚨 What is DeSci? With Paul Kohlhaas bio/acc CEO & Co-founder Bio Protocol & Alex Mukhin Co-lead . In this episode below we discuss: - What exactly is DeSci? - How is set to increase human longevity - How does crypto solve medical research? - Medical investment incentives - What is VITA-FAST? - How is development enforced - What are the traditional medical investment dynamics? - Is DeSci a hype cycle? - What is Pump Science & $RIF? - DeSci's roadmap Full ep in this tweet or via links below: 📺Youtube: 🎙️Spotify: 🎙️Apple: -- Timestamps: (00:00) Introduction (02:28) What is DeSci? (03:35) Paul’s background (07:27) VitaDAO user experience (09:34) VitaDAO’s use case (12:17) How does crypto solve medical research? (16:44) VitaDAO demographic (19:50) Investment incentives (24:09) VITA-FAST (27:05) Development enforcement (32:14) Traditional medical investment dynamics (35:07) Is DeSci a hype cycle? (40:08) What is & $RIF? (45:22) DeSci roadmap (49:35) Outro --
52:04

🚨NEW EPISODE🚨 What is DeSci? With Paul Kohlhaas bio/acc CEO & Co-founder Bio Protocol & Alex Mukhin Co-lead . In this episode below we discuss: - What exactly is DeSci? - How is set to increase human longevity - How does crypto solve medical research? - Medical investment incentives - What is VITA-FAST? - How is development enforced - What are the traditional medical investment dynamics? - Is DeSci a hype cycle? - What is Pump Science & $RIF? - DeSci's roadmap Full ep in this tweet or via links below: 📺Youtube: 🎙️Spotify: 🎙️Apple: -- Timestamps: (00:00) Introduction (02:28) What is DeSci? (03:35) Paul’s background (07:27) VitaDAO user experience (09:34) VitaDAO’s use case (12:17) How does crypto solve medical research? (16:44) VitaDAO demographic (19:50) Investment incentives (24:09) VITA-FAST (27:05) Development enforcement (32:14) Traditional medical investment dynamics (35:07) Is DeSci a hype cycle? (40:08) What is & $RIF? (45:22) DeSci roadmap (49:35) Outro --

BLOCKCRUNCH

11,198 views • 1 year ago

Rocket scientists and engineers use their High IQs to bridge the gap in interplanetary travel to mars #HeyWhiteCulture
0:50

Rocket scientists and engineers use their High IQs to bridge the gap in interplanetary travel to mars #HeyWhiteCulture

The Black Tucker Carlson Jr 🇺🇸

36,212 views • 1 year ago

I came across this man on TikTok sharing valuable insights on how to approach mechanized farming truly enlightening and inspiring for Nigeria’s agricultural growth ❤️🇳🇬
0:39

I came across this man on TikTok sharing valuable insights on how to approach mechanized farming truly enlightening and inspiring for Nigeria’s agricultural growth ❤️🇳🇬

A. Ayofe

14,023 views • 1 year ago

I prepared more content Bio gave me 0 xp The team does not make any statements Bio passes it off with memorized sentences Tell me there's a mistake Bio Protocol BiomeAI biome Paul Kohlhaas bio/acc Aubrai Marcille
0:24

I prepared more content Bio gave me 0 xp The team does not make any statements Bio passes it off with memorized sentences Tell me there's a mistake Bio Protocol BiomeAI biome Paul Kohlhaas bio/acc Aubrai Marcille

YncCrypto

12,675 views • 9 months ago

This ARMY has documented all the instances there have been updates on the guys this year. 1960 times. ONE THOUSAND NINE HUNDRED AND SIXTY instances were recorded. Link to the document on the acc bio.
1:02

This ARMY has documented all the instances there have been updates on the guys this year. 1960 times. ONE THOUSAND NINE HUNDRED AND SIXTY instances were recorded. Link to the document on the acc bio.

JRJ ㉧㉣㉣

406,145 views • 6 months ago

“People don’t invest in mumbo jumbo medical papers, they invest in the story of making the human experience better. Data explains, but story inspires. That’s how you get people behind the mission.” Arthur Hayes at the fireside chat with Paul Kohlhaas bio/acc at DeSci Singapore 2025
1:11

“People don’t invest in mumbo jumbo medical papers, they invest in the story of making the human experience better. Data explains, but story inspires. That’s how you get people behind the mission.” Arthur Hayes at the fireside chat with Paul Kohlhaas bio/acc at DeSci Singapore 2025

Bio Protocol

67,442 views • 9 months ago

It’s time for a new and modern approach to international development.
1:13

It’s time for a new and modern approach to international development.

Foreign, Commonwealth & Development Office

52,941 views • 1 year ago

DeSci Belgrade is exciting, but how exciting is DeSci really? We asked DeSci enthusiasts from GeroSense Ethernity Cloud, DeSci Belgrade and DeSciWorld about their thoughts. Add up to the excitement by sharing your thoughts on how desci is changing the industry. $NOBL #ICP #DeSci
1:20

DeSci Belgrade is exciting, but how exciting is DeSci really? We asked DeSci enthusiasts from GeroSense Ethernity Cloud, DeSci Belgrade and DeSciWorld about their thoughts. Add up to the excitement by sharing your thoughts on how desci is changing the industry. $NOBL #ICP #DeSci

NOBLEBLOCKS

11,756 views • 2 years ago

.Ochre Bio is on a mission to revolutionize liver disease treatment. Co-Founder + CEO Jack O'Meara talks with Judy Khan Shaw about their 'human first' approach and how machine learning technology sets them apart in drug development on #NYSEFloorTalk.
5:42

.Ochre Bio is on a mission to revolutionize liver disease treatment. Co-Founder + CEO Jack O'Meara talks with Judy Khan Shaw about their 'human first' approach and how machine learning technology sets them apart in drug development on #NYSEFloorTalk.

NYSE 🏛

19,813 views • 2 years ago

The bridge is Live: Real development takes time. Easier to have ChatGPT write a Whitepaper and ask every KOL to shill. From now on, we can finally follow up with a lot more Business Development!
4:59

The bridge is Live: Real development takes time. Easier to have ChatGPT write a Whitepaper and ask every KOL to shill. From now on, we can finally follow up with a lot more Business Development!

BRCport

259,160 views • 2 years ago